Skip to main content
Premium Trial:

Request an Annual Quote

Kinaxo Receives European Patent for Chemical Proteomics Technology

Premium

This story originally ran on April 12.

Kinaxo Biotechnologies said this week it has been granted a European patent covering its proteomics technology.

Entitled "Proteome-wide quantification of small molecule binding to cellular target proteins," the patent encompasses the company's Cellular Target Profiling, KinAffinity, and Epigenetics Target Profiling services.

Kinaxo's KinAffinity and Epigenetics Target products combine chemical proteomics methods with quantitative mass spectrometry to generate target selectivity data for kinase inhibitors and epigenetic drugs, respectively. The Cellular Target Profiling service offers analysis of potential off-target interactions for compounds across the proteome of a given cell line or tissue sample.

Such data "significantly supports decision-making at various stages of the drug development process," said Henrik Daub, Kinaxo's chief technology officer, in a statement.

The company, which drug developer Evotec agreed in February to purchase for up to €16 million ($22 million) in cash and stock (GWDN 02/09/2011), has inked a number of deals in recent months for the use of its technology, with customers including pharmaceutical firms like Takeda (PM 03/18/2011), AstraZeneca (PM 01/07/2011), and Bristol-Myer Squibb (GWDN 10/11/2010).

Patent applications for the technology are pending in the United States and Japan, Kinaxo said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.